These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 9114906)

  • 1. The influence of orally deposited budesonide on the systemic availability of budesonide after inhalation from a Turbuhaler.
    Pedersen S; Steffensen G; Ohlsson SV
    Br J Clin Pharmacol; 1993 Sep; 36(3):211-4. PubMed ID: 9114906
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lung deposition of budesonide from Turbuhaler is twice that from a pressurized metered-dose inhaler P-MDI.
    Thorsson L; Edsbäcker S; Conradson TB
    Eur Respir J; 1994 Oct; 7(10):1839-44. PubMed ID: 7828694
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lower oropharyngeal deposition of inhaled ciclesonide via hydrofluoroalkane metered-dose inhaler compared with budesonide via chlorofluorocarbon metered-dose inhaler in healthy subjects.
    Nave R; Zech K; Bethke TD
    Eur J Clin Pharmacol; 2005 May; 61(3):203-8. PubMed ID: 15824911
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Equivalent lung deposition of budesonide in vivo: a comparison of dry powder inhalers using a pharmacokinetic method.
    Lähelmä S; Kirjavainen M; Kela M; Herttuainen J; Vahteristo M; Silvasti M; Ranki-Pesonen M
    Br J Clin Pharmacol; 2005 Feb; 59(2):167-73. PubMed ID: 15676038
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lung deposition and systemic availability of fluticasone Diskus and budesonide Turbuhaler in children.
    Agertoft L; Pedersen S
    Am J Respir Crit Care Med; 2003 Oct; 168(7):779-82. PubMed ID: 12893646
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical efficacy and safety of budesonide Turbuhaler as compared to MDIs in children.
    Pedersen S
    J Aerosol Med; 1994; 7(Suppl 1):S67-71. PubMed ID: 10147083
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lung deposition of budesonide inhaled via Turbuhaler: a comparison with terbutaline sulphate in normal subjects.
    Borgström L; Bondesson E; Morén F; Trofast E; Newman SP
    Eur Respir J; 1994 Jan; 7(1):69-73. PubMed ID: 8143834
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Equivalent Lung Dose and Systemic Exposure of Budesonide/Formoterol Combination via Easyhaler and Turbuhaler.
    Lähelmä S; Sairanen U; Haikarainen J; Korhonen J; Vahteristo M; Fuhr R; Kirjavainen M
    J Aerosol Med Pulm Drug Deliv; 2015 Dec; 28(6):462-73. PubMed ID: 25757188
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of the antiasthmatic, oropharyngeal, and systemic glucocorticoid effects of budesonide administered through a pressurized aerosol plus spacer or the Turbuhaler dry powder inhaler.
    Toogood JH; White FA; Baskerville JC; Fraher LJ; Jennings B
    J Allergy Clin Immunol; 1997 Feb; 99(2):186-93. PubMed ID: 9042043
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High lung deposition of 99mTc-labeled ciclesonide administered via HFA-MDI to patients with asthma.
    Newman S; Salmon A; Nave R; Drollmann A
    Respir Med; 2006 Mar; 100(3):375-84. PubMed ID: 16275052
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lung deposition of budesonide from the novel dry powder inhaler Airmax.
    Hirst RH; Newman SR; Clark DA; Hertog MG
    Respir Med; 2002 Jun; 96(6):389-96. PubMed ID: 12117037
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetic study for the establishment of bioequivalence of two inhalation treatments containing budesonide plus formoterol.
    Grekas N; Athanassiou K; Papataxiarchou K; Rizea Savu S; Silvestro L
    J Pharm Pharmacol; 2014 Dec; 66(12):1677-85. PubMed ID: 25109416
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical pharmacokinetics of inhaled budesonide.
    Donnelly R; Seale JP
    Clin Pharmacokinet; 2001; 40(6):427-40. PubMed ID: 11475468
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dose-proportional pharmacokinetics of budesonide inhaled via Turbuhaler.
    Kaiser H; Aaronson D; Dockhorn R; Edsbäcker S; Korenblat P; Källén A
    Br J Clin Pharmacol; 1999 Sep; 48(3):309-16. PubMed ID: 10510140
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of inhaler technique and achievement and maintenance of mastery of budesonide/formoterol Spiromax® compared with budesonide/formoterol Turbuhaler® in adult patients with asthma: the Easy Low Instruction Over Time (ELIOT) study.
    Price DB; Thomas V; Richard Dekhuijzen PN; Bosnic-Anticevich S; Roche N; Lavorini F; Raju P; Freeman D; Nicholls C; Small IR; Sims E; Safioti G; Canvin J; Chrystyn H
    BMC Pulm Med; 2018 Jun; 18(1):107. PubMed ID: 29954359
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Importance of the inhalation device on the effect of budesonide.
    Agertoft L; Pedersen S
    Arch Dis Child; 1993 Jul; 69(1):130-3. PubMed ID: 8024295
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Drug delivery from the Turbuhaler and Nebuhaler pressurized metered dose inhaler to various age groups of children with asthma.
    Agertoft L; Pedersen S; Nikander K
    J Aerosol Med; 1999; 12(3):161-9. PubMed ID: 10623332
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Budesonide administered via Turbuhaler and a nebulator].
    Agertoft L; Pedersen SE
    Ugeskr Laeger; 1994 Jul; 156(28):4134-7. PubMed ID: 8066909
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Deposition of corticosteroid aerosol in the human lung by Respimat Soft Mist inhaler compared to deposition by metered dose inhaler or by Turbuhaler dry powder inhaler.
    Pitcairn G; Reader S; Pavia D; Newman S
    J Aerosol Med; 2005; 18(3):264-72. PubMed ID: 16181001
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Equally efficacious asthma management with budesonide 800 micrograms administered by Turbuhaler or with beclomethasone dipropionate > or = 1500 micrograms given through a pressurized metered-dose inhaler with spacer. The French Budesonide Trial Group.
    Piquet J; Zuck P; Dennewald G; Dugue P; Grivaux M; Brun P; Severac JC; Ostinelli J; Cheeseman KH
    Adv Ther; 1996; 13(1):38-50. PubMed ID: 10172710
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.